Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 294
Selected: 0
NCT IDTitle
NCT03125642Auto Stem Cell Transplant for Lymphoma Patients
NCT02395822MT2014-25: Haplo NK With SQ IL-15 in Adult Relapsed or Refractory AML Patients
NCT00668564Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism
NCT00176904Stem Cell Transplant for Inborn Errors of Metabolism
NCT00855114Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery
NCT01639456CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploid Donor Natural Killer Cell Treatment in Older AML in First Complete Remission
NCT06213298Effect of Kava on Anxiety and Stress in Cancer Survivors
NCT00784524Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast Ca
NCT00095160Safety Study of an Immune Response Modifier in Patients With Refractory Solid Organ Tumors
NCT00287911Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer
NCT00006451Bone Marrow Transplantation in Treating Patients With Leukemia
NCT00392782Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease
NCT02118311Treg Cells for AGVHD in Non-myeloablative UCB Transplant
NCT02309944Negative Pressure Wound Therapy in Obese Gynecologic Oncology Patients
NCT03642626MT2017-45: CAR-T Cell Therapy for Heme Malignancies
NCT01681875Project 1, Study 1: Investigating the Impact of Nicotine Using Spectrum Cigarettes
NCT04629209A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma
NCT00176930Stem Cell Transplant for Hematological Malignancy
NCT02145039Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases
NCT02525029Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD
NCT04055844Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS
NCT01626092Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders
NCT03946423BAriaTric Surgery After Breast Cancer Treatment (BATS)
NCT03367546Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases
NCT00622674Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors
NCT00428194Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical Cancer
NCT07153016LEgal Guidance and AdvocaCY for CAREgivers (LEGACY CARE): A Pilot Clinical Trial for Caregivers of Persons With Colorectal Cancer
NCT00726739Aldesleukin With or Without Vaccine Therapy in Treating Patients With Stage IV Melanoma
NCT06594445HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML
NCT01601548Cancer and Mindfulness-Based Cancer Recovery After Chemotherapy
NCT05308316Sugars in Cigarettes
NCT02141451ADAM17 Inhibitor/ Rituximab After Auto HCT for DLBCL
NCT02988466Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT
NCT04514029Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel
NCT01666080Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
NCT00376805Allogeneic Natural Killer (NK) Cells in Patients With Advanced Metastatic Breast Cancer
NCT00400803Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung Cancer
NCT07541573GTB-5550 in Advanced Solid Tumors
NCT01505569Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
NCT03687073Trial of Indole-3-Carbinol and Silibinin
NCT02666105Exemestane in Post-Menopausal Women With NSCLC
NCT06342986Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
NCT01288222Selecting a Favorable KIR Donor in Unrelated HCT for AML
NCT00287859Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
NCT04530695Diagnosis and Treatment of Periodontal Disease in Patients With AML
NCT06322992App-Assisted Day Reconstruction to Reduce Treatment Burden and Logistic Toxicity in Cancer Patients - Aim 3
NCT00680667Clinical Trial of Trametes Versicolor in Women With Breast Cancer
NCT00167219Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML)
NCT03850691Radiation and Combination Immunotherapy for Melanoma
NCT07493538MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases